13 January 2017

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 13 January 2017 it granted options over a total of 950,000 ordinary shares of 0.2p each in the Company to Directors and PDMRs as detailed below.

Director Number
of options
granted
Exercise
price
Exercise period Total number
of options
held following
notification
Total number
of ordinary
shares held
           
J H Barder 250,000 57.50p 1 Oct 2018 - 30 Sep 2023 1,500,000 1,528,830
           
D A Martin 200,000 57.50p 1 Oct 2018 - 30 Sep 2023    860,000    280,000
           
K W James 200,000 57.50p 1 Oct 2018 - 30 Sep 2023   200,000      13,787

 

PDMR Number
of options
granted
Exercise
price
Exercise period Total number
of options
held following
notification
Total number
of ordinary
shares held
           
T Holland 150,000 57.50p 1 Oct 2018 - 30 Sep 2023   767,500   -
           
I Armstrong 150,000 57.50p 1 Oct 2018 - 30 Sep 2023    400,000    -
           

The new options were granted under the Futura Medical plc Unapproved Share Option Scheme with the exception of 124,348 options granted to J H Barder, 200,000 options granted to K W James and 150,000 options granted to I Armstrong which were granted under the Futura Medical plc Enterprise Management Incentive Scheme.

The main vesting condition of the options is that the Director/PDMR remain employed with the Company as at the date of exercise.

Further to the prior announcement of 12 January 2017 (RNS Number: 0646U) entitled, 'Director/ PDMR Dealing', the Company wishes to clarify that Mr. Barder's net shareholding increased by 40,000 shares as a result of the transactions described therein. 

 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000

 

Notes to editors:

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange (AIM: FUM).

www.futuramedical.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name James Barder
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2p each
GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
57.50 pence

250,000

d) Aggregated information
- Aggregated volume
- Price
Not applicable
e) Date of the transactions 13 January 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Derek Martin
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2p each
GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
57.50 pence

200,000

d) Aggregated information
- Aggregated volume
- Price
Not applicable
e) Date of the transactions 13 January 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Ken James
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2p each
GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
57.50 pence

200,000

d) Aggregated information
- Aggregated volume
- Price
Not applicable
e) Date of the transactions 13 January 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Tim Holland
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2p each
GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
57.50 pence

150,000

d) Aggregated information
- Aggregated volume
- Price
Not applicable
e) Date of the transactions 13 January 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Ian Armstrong
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2p each
GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes  
Price(s) Volume(s)
57.50 pence

150,000

d) Aggregated information
- Aggregated volume
- Price
Not applicable
e) Date of the transactions 13 January 2017
f) Place of the transactions Outside a trading venue